Pulse Biosciences, Inc.
PLSE
Classement en actions
#4258
Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric... Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric medicine. Their primary offering is the CellFX System, a sophisticated, console-based platform that is precisely controlled via software. This system utilizes its proprietary Nano-Pulse Stimulation technology to deliver extremely brief, nanosecond-duration electrical pulses. This advanced method is designed to selectively eliminate target cells without thermal damage, effectively safeguarding adjacent non-cellular tissue. The CellFX System is applied in the treatment of various medical conditions. The company, originally incorporated in 2014 as Electroblate, Inc., officially became Pulse Biosciences, Inc. in December 2015. Its corporate headquarters are situated in Hayward, California.
Prix de l'action
$52.14
Capitalisation boursière
$3.72B
Changement (1 jour)
1.62%
Changement (1 an)
202.26%
Pays
US
Échange Pulse Biosciences, Inc. (PLSE)
Catégorie
Healthcare
Historique du prix de l'action pour Pulse Biosciences, Inc. (PLSE)
Prix de clôture le plus élevé : $49.38 le 2026-10-01
Prix de clôture le plus bas : $4.20 le 2016-05-01
Prix de clôture le plus bas : $4.20 le 2016-05-01
Historique du prix de l'action de Pulse Biosciences, Inc. de 2016 à 2026
Performance annuelle du prix de l'action
| Année | Performance |
|---|---|
| 2026 (TTM) | 91.55% |
| 2025 | -23.80% |
| 2024 | 72.60% |
| 2023 | 322.28% |
| 2022 | -84.88% |
| 2021 | -15.48% |
| 2020 | 41.40% |
| 2019 | 19.04% |
| 2018 | -50.17% |
| 2017 | 306.74% |
| 2016 | 0.00% |
Prix de l'action pour des entreprises similaires ou concurrentes
| Entreprise | Prix de l'action | Variation 1a% | Pays |
|---|---|---|---|
| $439.79 | -16.55% |
US
|
|
| $197.65 | -45.34% |
FR
|
|
| $170.48 | 12.48% |
JP
|
|
| $198.33 | 34.11% |
US
|
|
| $69.95 | -8.61% |
CH
|
